The global digital twin in healthcare market, valued at USD 2.5 billion in 2025, is projected to reach USD 3.4 billion in 2026 and USD 33.4 billion by 2035, with a 28.8% CAGR during the forecast period 2026 to 2035. According to a recent study, healthcare executives anticipate a significant increase in investment from pharmaceutical players with over 65% increased investment expected in this domain in the next three years. Digital twins also find their application in accelerating the pace of...

The global veterinary ultrasound market is valued at USD 0.43 billion in 2024 and is poised to reach USD 0.73 billion by 2035, representing a CAGR of 4.96% during the forecast period.

The global 3D printed drugs market size is valued at USD 281.63 million in 2024 and is poised to reach at USD 605.09 million by 2035, representing a CAGR of 7.20% during the forecast period. In September 2024, the APL (Leading manufacturer of extemporaneous medicine) and CurifyLabs (Finnish Health Tech Company) forged a collaboration deal to increase the administration of medicines to children using advanced 3D printing technology. Examples of key players engaged in this domain (which have also...

The global oligonucleotide synthesis market, valued at USD 5.7 billion in 2025, is projected to reach USD 6.8 billion in 2026 and USD 13.5 billion by 2035, with a 7.9% CAGR during the forecast period 2026 to 2035. In terms of application area, the research and diagnostics segment holds the highest share (~60%) of the market. Based on the type of oligonucleotide synthesized, the antisense oligonucleotide segment holds the largest market share (more than 60%).  With respect to scale of operatio...

The global medical device market size is anticipated to increase from USD 528.88 billion in 2024 to reach USD 857.39 billion by 2035, growing at a CAGR of 4.49% during the forecast period. In November 2024, Boston Scientific acquired Axonics, a medical technology company focused on development of devices for the treatment of bowel and urinary dysfunction. As stated by Meghan Scanlon, Senior Vice President and President, Urology, Boston Scientific,

The global telehealth services market size is estimated to grow from USD 60.48 billion in 2024 to USD 784.95 billion by 2035, growing at a CAGR of 26.24% during the forecast period. According to the Centers for Disease Control and Prevention, approximately 129 million people in the United States suffer from at least one major chronic condition, such as cancer, heart disease, diabetes, obesity and hypertension. This high prevalence of chronic diseases is expected to continue during the upcoming y...

The oncology precision medicine market, valued at USD 166 billion in 2025, is project to reach USD 185 billion in 2026 and USD 364 billion by 2035, representing a CAGR of 7.8% during the forecast period 2026 to 2035. In terms of type of cancer targeted, the blood / hematologic cancer segment holds the highest share (~25%) of the market. Based on the type of molecule, the biologics segment holds the largest market share (nearly 60%). With respect to drug class, kinase inhibitor captures the highe...

The global microbiome manufacturing market size is estimated to grow from USD 40.6 million in 2024 to USD 186.7 million by 2035, representing a CAGR of 14.9% during the forecast period. It is worth highlighting that, in November 2022, the US Food and Drug Administration (FDA) approved the first microbiome-based therapy, RBX2660 (developed by Rebiotix) for the treatment of recurrent Clostridium difficile infection. Notably, in April 2023, SER-109, a microbiome-based first oral therapy developed b...

The global malaria diagnostics market size is valued at USD 0.85 billion in 2024 and is projected to reach USD 1.45 billion by 2035, representing a CAGR of 5.0% during the forecast period. As per the World Health Organization (WHO) report, in 2022, nearly 6,08,000 people died due to malaria and 249 million new cases were reported in 2022. Of these, 94% cases were identified in the African region. In order to mitigate the growing concern of malaria, WHO has recommended early parasite-based diagno...

The medical aesthetics market, valued at USD 37.6 billion in 2024, is project to reach USD 40.9 billion in 2025 and USD 102.3 billion by 2035, representing a CAGR of 9.6% during the forecast period 2025 to 2035. Based on the end user, the clinics / medical spas, dermatology centers / cosmetic centers segment holds the largest market share (nearly 50%) in 2025. With respect to gender, females capture the highest share (90%). North America captures majority of the market share. Notably, Asia-Pacif...

The cell line characterization and cell line development market, valued at USD 2.71 billion in 2025, is projected to grow to USD 3.14 billion in 2026 and USD 8.38 billion by 2035, representing a CAGR of 11.5% during the forecast period. Cell line development and cell line authentication is a cost-intensive and complex process that requires multidisciplinary expertise. In fact, considering their critical role in drug discovery and development, cell lines need to be appropriately tested and valida...

The global home healthcare market size is valued at USD 311.66 billion in 2024 and is projected to reach USD 719.31 billion by 2035, representing a CAGR of 7.90% during the forecast period. North America currently accounts for the highest share (51%) of the market. Currently, services occupy an 85% share of the market with products accounting for the rest. The global market for home healthcare will also be propelled by increasing patient preferences for remote care and technological advancements...

The global cold chain market for pharmaceuticals, valued at USD 6.6 billion in 2025, is projected to reach USD 6.9 billion in 2026 and USD 9.6 billion by 2035, with a 3.8% CAGR during the forecast period, 2026 to 2035. The pharma cold chain specifically addresses the requirements of freezing / cryogenic holding temperature for a wide variety of temperature sensitive pharmaceutical products, such as biologics, covid vaccines, human organs, and certain conventional pharmacological interventions, s...

The global rehabilitation robots market size is estimated to grow from USD 0.29 billion in 2024 to USD 1.33 billion by 2035, representing a CAGR of 15% during the forecast period. In 2024, the World Health Organization reported that more than 15 million people are living with spinal cord injuries and the majority of these causes are due to accidental falls, road accidents and trauma. This rising incidence of spinal cord injuries has underscored the demand for rehabilitation robots, specifically...

The global chronic kidney disease market size is valued at USD 38.91 billion in 2024 and is expected to reach USD 67.36 billion by 2035, representing a CAGR of 5.12% during the forecast period. Chronic kidney disease (CKD) refers to the long-term condition in which a patient gradually loses its kidney function. In most cases, patients suffering from chronic kidney disease remain undiagnosed until the kidney function declined to 75% as its symptoms are rarely observed (which include swollen ankle...

The global retinal biologics market size is currently valued at $ 25.65 billion and is poised to reach $ 57.47 billion by 2035, it is estimated to grow at a CAGR of 7.61%, during the forecast period. There has been a surge in the number of patients suffering from various retinal diseases, such as diabetic retinopathy, glaucomatous retinal degeneration and age-related macular degeneration. As per the World Health Organization, in 2023, nearly 2.2 billion people have near, or distance vision impai...

The smart inhalers market size is valued at USD 1.53 billion in 2024 and is expected to reach USD 5.84 billion by 2035, representing a CAGR of 12.95% during the forecast period 2024-2035. According to our projection, currently hospital pharmacies occupy the highest share (nearly 45%) of the market owing to flexibility, convenience and comfort of purchasing smart inhalers in the healthcare settings for hospitalized patients. Furthermore, there is an increase in the number of hospitalized patients...

The global drug delivery technologies market is currently valued at $0.52 billion and is poised to reach $6.42 billion by 2035, at a CAGR of 25.5%, during the forecast period. Given the inherent requirement for frequent medication, patients suffering from such long-lasting clinical conditions generally end up spending high amounts on not only the prescribed therapeutic regimen, but also on numerous hospital visits for dose administration. Since 2018, more than 250 biologics (including antibody d...

Viral sensitizers market, a notable segment of the viral manufacturing consumables market, is anticipated to grow at a compounded annual growth rate (CAGR) of 14% during the forecast period. Over the last two decades, the gene therapy industry has witnessed several breakthroughs including the FDA approval of Abecma for the treatment of adult patients with relapsed or refractory multiple myeloma and the commercialization approval of Libmeldy

The global surgical sutures market is estimated to grow from $4.79 billion in 2024 to $8.70 billion by 2035, at a steady CAGR of 5.57% during the forecast period. In September 2024, Meril announced the launch of New Edge suture that has enhanced durability, precision and reliability and minimizes the risk of complication and re-surgery. Further, in October 2024, Globus Medical announced the launch of TENSOR